Journal
WORLD NEUROSURGERY
Volume 165, Issue -, Pages E159-E168Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.wneu.2022.05.121
Keywords
Basal ganglia; GABA(A) receptor; Globus pallidus; Immunofluorescence; Parkinson disease; Receptor subunit
Categories
Funding
- University of Virginia Medical Student Summer Research Program
Ask authors/readers for more resources
This study suggests that compensatory changes in the expression of GABA(A) receptor alpha 1 and alpha 3 subunits do not occur in the globus pallidus of Parkinson's disease patients.
BACKGROUND:The gamma-aminobutyric acid A (GABA(A)) receptor is an important mediator of cellular signaling in the globus pallidus and might be implicated in the pathophysiology of Parkinson disease (PD). The goal of the present study was to characterize GABA(A) receptor subunit expression in the normal and parkinsonian human globus pallidus. METHODS: Postmortem brain specimens were obtained from 8 patients with pathological evidence of PD at autopsy and from 4 control patients without such evidence. These tissues were exposed to primary antibodies directed against the alpha 1 and alpha 3 subunits of the GABA(A) receptor and were visualized and quantified using fluorescence microscopy. RESULTS: No differences were found in the pallidal neuronal density in the control versus PD tissues. Projection neurons strongly expressed the alpha 1, alpha 3, and beta 2 GABA(A) receptor subunits. After normalizing the immunofluorescence intensities in the globus pallidus to those in the adjacent structures, no significant differences were found in GABA(A) receptor subunit expression in the globus pallidus between the PD specimens and the control specimens. CONCLUSIONS: Compensatory changes in GABA(A) receptor alpha 1 and alpha 3 subunit expression in response to PD-related signaling abnormalities in the globus pallidus did not occur in our PD cohort.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available